FLG and Alzheimer disease: Here it is important to emphasize that reduced filaggrin levels are also observed in AD patients who are genotypically the wild type for FLG [65,71], demonstrating that FLG variants are not the only factors responsible for filaggrin downregulation in AD skin, and that other factors (e.g., environmental, metabolic) are also likely to be involved.